PROFERO - Trademark Details
Status: 734 - Fifth Extension - Granted
Serial Number
88000887
Word Mark
PROFERO
Status
734 - Fifth Extension - Granted
Status Date
2022-01-12
Filing Date
2018-06-14
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-05-14
Attorney Name
Law Office Assigned Location Code
L60
Employee Name
MICKLEBURGH, LINDA BOH
Statements
Goods and Services
Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for scientific research purposes; Reagents for scientific or medical research use; Clinical diagnostic preparations for clinical or medical laboratory use
Goods and Services
Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic properties; Diagnostic agents, preparations and substances for medical purposes; Medical diagnostic reagents for the analysis of genetic material; Preparations for detecting changes in genes and gene expressions for medical purposes; Chemical reagents for medical analysis; Chemical preparation for use in medical analysis, particularly DNA analysis; Pharmaceutical preparations for diagnosis and for identifying and characterizing genetic abnormalities, tracking the progress of disease and measuring the effectiveness of therapies; Genetic identity tests comprises of reagents for medical purposes; Clinical diagnostic preparations for medical use
Goods and Services
Laboratory diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical and scientific research in the field of genetic testing and diagnosis and treatment of medical conditions; Development of tests and laboratory testing in the field of genetics and human disease; Scientific research consulting in the field of genetics, genomics, nucleic acid sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; Nucleic acid collection, testing and analysis services for scientific research purposes; Genetic testing for scientific diagnostic research purposes; Genomic testing for scientific diagnostic research purposes; Medical and scientific research, development and consulting in the field of neurology; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of disease treatment and diagnosis; Medical and scientific research relating to the design and development of treatment therapies; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data for research or analysis purposes; Conducting clinical and pre-clinical trials; Targeted pharmaceutical drug development services; Genotyping services for research or analysis purposes; Gene screening for research or analysis purposes; Gene isolation and gene expression analysis for scientific and medical research purposes; Gene mapping; Gene analysis and biomarker discovery for scientific research and medical purposes; Research and development of identification and treatment methods for hereditary factors leading to disease; Nucleic acid-sequencing for scientific research purposes
Goods and Services
Medical diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical testing, analysis, and evaluation services for medical or diagnostic purposes for providing healthcare information; Providing health care information featuring information resulting from genomic research, testing, analysis, and evaluation; Diagnosis and treatment of medical conditions, namely, of cognitive, neurological, and brain-related conditions; Providing healthcare information; Providing information in the field of disease prevention, screening, diagnosis, and treatment for medical diagnostic and treatment purposes; Medical testing services for diagnostic or treatment purposes in the medical field; Proteogenomic profiling for diagnostic or treatment purposes of cognitive, neurological, and brain-related conditions; Identification of target molecules for disease treatment, namely, treatments of cognitive, neurological, and brain-related conditions
Translation of Words in Mark
The English translation of "PROFERO" in the mark is "DELAY".
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2018-06-20
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-06-20
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-06-20
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-06-20
Primary Code
044
Current Trademark Owners
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Bradley P. Hartman
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2018-06-18 | NEW APPLICATION ENTERED IN TRAM |
2018-06-20 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-09-04 | ASSIGNED TO EXAMINER |
2018-09-10 | NON-FINAL ACTION WRITTEN |
2018-09-10 | NON-FINAL ACTION E-MAILED |
2018-09-10 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-03-08 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-03-11 | ASSIGNED TO LIE |
2019-03-13 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-03-13 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-04-01 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-04-24 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-05-14 | PUBLISHED FOR OPPOSITION |
2019-05-14 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-07-09 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2019-12-16 | TEAS EXTENSION RECEIVED |
2019-12-16 | EXTENSION 1 FILED |
2019-12-16 | EXTENSION 1 GRANTED |
2019-12-18 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-07-01 | TEAS EXTENSION RECEIVED |
2020-07-01 | EXTENSION 2 FILED |
2020-07-01 | EXTENSION 2 GRANTED |
2020-07-03 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-12-22 | TEAS EXTENSION RECEIVED |
2020-12-22 | EXTENSION 3 FILED |
2020-12-22 | EXTENSION 3 GRANTED |
2020-12-24 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-07-02 | TEAS EXTENSION RECEIVED |
2021-07-02 | EXTENSION 4 FILED |
2021-07-02 | EXTENSION 4 GRANTED |
2021-07-06 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2022-01-05 | TEAS EXTENSION RECEIVED |
2022-01-12 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2022-01-05 | EXTENSION 5 FILED |
2022-01-12 | EXTENSION 5 GRANTED |
2022-01-13 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |